Debiopharm Group - redOrbit

Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis

2012-05-14 22:20:48

LAUSANNE and VILLARS-SUR-GLÂNE, Switzerland, May 15, 2012 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm) and Vifor Pharma announce the signing of an exclusive agreement

Debiopharm and Curis Announce Initiation of Phase Ib Expansion Study of HSP90 Inhibitor Debio 0932

2012-02-16 06:00:00

LAUSANNE, Switzerland and LEXINGTON, Massachusetts, February 16, 2012 /PRNewswire/ -- Curis, Inc.

Augurix Diagnostics Receives the 2011 'Debiopharm /Valais Award' for its Point-of-care Diagnostic Test for the Early Detection of Celiac Disease

2011-11-09 04:07:00

LAUSANNE, Switzerland, November 9, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group with a focus on drug development

The Japanese Cancer Association and Debiopharm Group(TM) Present Doctors Arakawa and Kurokawa With the 2011 'JCA-Mauvernay Award' for Their Innovative and Outstanding Research in the Field of Cancer

2011-10-05 03:00:00

LAUSANNE, Switzerland, October 5, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group with a focus on drug development

Debiopharm Group(TM) Presents the 'Debiopharm Group(TM) Life Sciences Award 2011' and two 'Junior Debiopharm Group(TM) Awards 2011' at the ISREC 2011 Life Sciences Symposium

2011-09-08 03:00:00

LAUSANNE, Switzerland, September 8, 2011 /PRNewswire/ -- Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical group with a focus on drug development

News - Debiopharm Group

Breaking News

Streaming Video

Images and Photos

Space Exploration

Science and Research

Technology

My Health